In this study spinel‐lithium manganese oxide (LiMn2O4) powders were prepared by using a simple sol–gel method with polyvinyl alcohol (PVA), and further combined with a conductive additive, graphene, to produce a composite electrode material for improved performance. The effects of the variation in the ratios of binder (PVA) to LiMn2O4 precursor on the particle size and electrochemical behavior of the composite were studied. Particle sizes of <200 nm were obtained. An energy density of 17.36 Wh kg−1 was obtained at an operating voltage of 3.2 V for the pure LiMn2O4 sample tested against a graphene electrode. For simultaneously improving power density (current Li batteries have a low power density as a disadvantage) along with energy density, the LiMn2O4–graphene composite was chosen as an electrode material. LiMn2O4–graphene composite electrodes were prepared by electrophoretic co‐deposition. The ratio of LiMn2O4–graphene composite was optimized to 1:1 during the electrode study based on its electrochemical performance. An average energy density of 30 Wh kg−1, a specific capacity of 49 mAh g−1, and an enhanced power density of 800 W kg−1 at a discharge current of 0.5 A g−1 were obtained. Discharge behavior improved evidently for tests performed on composite electrodes with increased LiMn2O4 (1:1.3 graphene/LiMn2O4). An improved average energy density of 59.6 Wh kg−1 was obtained along with a power density of 697 W kg−1. The electrodes showed good performance during study of a button cell device. Such electrodes are well suited for hybrid energy storage devices having good energy and power density and bridging the gap between batteries and supercapacitors.
MutT homolog1 (MTH1) is an enzyme responsible for removing oxidized nucleotides from cells. The activation of MTH1 has been reported in a number of cancer cell types and is considered to be responsible for imparting resistance towards anticancer drugs. While there are several known mechanisms for the activation of MTH1 in cancer cells, the present study aimed to evaluate the role of mutant isocitrate dehydrogenase1 (mIDH1)-mediated reactive oxygen species (ROS) production in the activation of MTH1 in glioma cells. MTH1 was found to be upregulated in both mIDH1-expressing cells and 2-hydroxyglutarate (2-HG)-treated cells. mIDH1 and its product, 2-HG, increased the levels of ROS in cultured glioblastoma cells. Furthermore, the increased expression and activity of MTH1 were observed in glioma tissues harboring mIDH1 compared to tissues with wild-type IDH1. On the whole, the findings of the present study unveil a novel mechanism of activation of MTH1 in glioma cells harboring mutant IDH1.
The present study reports an approach by which thin films of sucrose added olivine type LiMnPO4-Ccomposite and pristine LiMnPO4 is made by a technique of electrophoretic co-deposition in which pristine and composite samples were synthesized by a sol-gel route. These thin films with enhanced surface area is used to fabricate cathodes for rechargeable Li ion batteries. XRD confirms phase pure single crystalline orthorhombic structure. Transmission Electron Microscopy (TEM) images shows the carbon coating over LiMnPO4 and the particle size restricted in the nano regime. The presence of sp2 hybridized carbon on LiMnPO4 particles is confirmed by X-ray Photon spectroscopy (XPS). To explore the electrochemical behavior, cyclic voltammetry (CV) and cycling studies were performed. The specific capacity for LiMnPO4-C is found to be increased by 43% in comparison to the pristine LiMnPO4. It also exhibited 86% retention in capacity compared to the pristine LiMnPO4 (52%). The result indicates that a proper carbon coating can significantly improve the electronic conductivity and hence the specific capacity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.